| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.099 | 0.09 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |